17159613|t|Posterior cingulate neurometabolite profiles and clinical phenotype in frontotemporal dementia.
17159613|a|Proton magnetic resonance spectroscopy was used to compare metabolite levels from a posterior cingulate voxel in a group of patients with 2 syndromic subtypes of frontotemporal dementia (n=10) and an age and education-matched group with Alzheimer disease (n=10). Overall, frontotemporal dementia was indistinguishable from Alzheimer disease, though differences in N-acetylaspartate emerged between patients with the SD and progressive nonfluent aphasia subtypes, attributable to 2 atypical results among the latter. Such values may index cases with atrophy in posterior cortical regions presenting with progressive nonfluent aphasia.
17159613	71	94	frontotemporal dementia	Disease	MESH:D057180
17159613	220	228	patients	Species	9606
17159613	258	281	frontotemporal dementia	Disease	MESH:D057180
17159613	333	350	Alzheimer disease	Disease	MESH:D000544
17159613	368	391	frontotemporal dementia	Disease	MESH:D057180
17159613	419	436	Alzheimer disease	Disease	MESH:D000544
17159613	460	477	N-acetylaspartate	Chemical	MESH:C000179
17159613	494	502	patients	Species	9606
17159613	512	514	SD	Disease	MESH:D012735
17159613	519	548	progressive nonfluent aphasia	Disease	MESH:D057178
17159613	645	655	atrophy in	Disease	MESH:D001284
17159613	666	674	cortical	Disease	MESH:D054220
17159613	699	728	progressive nonfluent aphasia	Disease	MESH:D057178
17159613	Association	MESH:C000179	MESH:D057180
17159613	Association	MESH:C000179	MESH:D057178
17159613	Association	MESH:C000179	MESH:D012735

